FDA Drug Shortage Database
Triamcinolone (Kenalog) shortage
No triamcinolone presentation is listed as limited or unavailable in the FDA Drug Shortage Database (read October 8, 2026); it keeps 1 current entry listed as available (updated September 15, 2026). ASHP keeps a separate shortage list, which can differ.
- Generic listed
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 40mg/1ml injection | 0 | 0 | 1 |
| 40mg/2ml injection | 0 | 1 | 0 |
Which presentations are listed?
Listed now, available (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Medexus | Current posted May 4, 2021, updated September 15, 2026 | Available |
Resolved or discontinued (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) | Harrow Eye, LLC | Resolved posted September 27, 2021, updated July 31, 2026 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage